KHN Morning Briefing

Summaries of health policy coverage from major news organizations

Generic Drugmaker Liability Question To Be Argued Tuesday Before The High Court

Reuters: Top Court To Hear Arguments Over Generic Drugmaker Liability
The Supreme Court will hear arguments on Tuesday in a case that could decide whether generic drugmakers can be held liable for alleged flaws in the designs of their medications, even though federal law requires generic manufacturers to copy the brand drugmaker's design. The case, closely watched by pharmaceutical companies, regulators and lawyers, could determine the extent to which individuals can hold generic drug manufacturers liable for injuries allegedly caused by their copycat products (Baynes, 3/18).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.